U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H36N.C2H3O2
Molecular Weight 301.5078
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Hexadecylammonium acetate

SMILES

CC([O-])=O.CCCCCCCCCCCCCCCC[NH3+]

InChI

InChIKey=ANRCSZILOHNONR-UHFFFAOYSA-N
InChI=1S/C16H35N.C2H4O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17;1-2(3)4/h2-17H2,1H3;1H3,(H,3,4)

HIDE SMILES / InChI

Molecular Formula C16H36N
Molecular Weight 242.4637
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H3O2
Molecular Weight 59.044
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://goo.gl/iiVd6z | https://www.ncbi.nlm.nih.gov/pubmed/9299082

Cetylamine is an aliphatic primary amine that possesses surface-active properties and widely used in water treatment. Cetylamine shows moderate anti-tuberculosis activity. Cetylamine also may be used as a source of fluoride in the prevention of dental caries.

Originator

Sources: Recueil des Travaux Chimiques des Pays-Bas et de la Belgique (1927), 46, 208-11.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Low-temperature large-scale synthesis and electrical testing of ultralong copper nanowires.
2010-11-02
Controlled synthesis and characterization of ZnSe quantum dots.
2010-11
2-Pyridyl selenolates of antimony and bismuth: Synthesis, characterization, structures and their use as single source molecular precursor for the preparation of metal selenide nanostructures and thin films.
2010-10-07
Clinical effectiveness of contemporary dentin bonding agents.
2010-10
Single-molecule precursor-based approaches to cobalt sulphide nanostructures.
2010-09-28
Interfacial Cu/ZnO contact by selective photodeposition of copper onto the surface of small ZnO nanoparticles in non-aqueous colloidal solution.
2010-09-07
Testing the interaction between analytical modules: an example with Roundup Ready soybean line GTS 40-3-2.
2010-08-05
Complementary amphiphilic ribonucleotides confined into nanostructured environments.
2010-07-28
Solid-state 51V NMR investigation of the intercalation of alkylamines into layered alpha-vanadyl phosphate.
2010-06-15
Synthesis, self-assembly, disassembly, and reassembly of two types of Cu2O nanocrystals unifaceted with {001} or {110} planes.
2010-05-05
Effect of spacer length of alkanediyl-alpha,omega-bis(dimethylcetylammonium bromide) gemini homologues on the interfacial and physicochemical properties of BSA.
2010-05-01
Urea-stabilized air-stable Pt nanoparticles for thin film deposition.
2010-04-21
Platinum-vanadium oxide nanotube hybrids.
2010-04-09
Effect of spacer length on the micellization and interfacial behavior of mixed alkanediyl-alpha,omega-bis(dimethylcetylammonium bromide) Gemini homologues.
2010-04-01
Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
2010-04
Synthesis of monodisperse mesoporous titania beads with controllable diameter, high surface areas, and variable pore diameters (14-23 nm).
2010-03-31
Microcontact printing onto oxide-free silicon via highly reactive acid fluoride-functionalized monolayers.
2010-03-08
Effect of hyaluronic acid amide derivative on equine synovial fluid viscoelasticity.
2010-03-01
Interface enhancement of glass fiber/vinyl ester composites with carbon nanotubes synthesized from ethanol flames.
2010-02
Well-aligned Nickel Nanochains Synthesized by a Template-free Route.
2009-12-25
Molecular momentum transport at fluid-solid interfaces in MEMS/NEMS: a review.
2009-10-29
Enhancing the photoluminescence of polymer-stabilized CdSe/CdS/ZnS core/shell/shell and CdSe/ZnS core/shell quantum dots in water through a chemical-activation approach.
2009-10-06
Structure of liquid crystalline aerosol-OT and its alkylammonium salts.
2009-09-15
Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.
2009-08-13
Combinatorial library of primaryalkylammonium dicarboxylate gelators: a supramolecular synthon approach.
2009-08-04
Silica nanoparticles grown and stabilized in organic nonalcoholic media.
2009-07-07
Highly monodisperse colloidal magnesium nanoparticles by room temperature digestive ripening.
2009-05-18
Reaction of alkylamine surfactants with carbon dioxide: relevance to nanocrystal synthesis.
2009-05
Synthesis of the nickel selenophosphinates [Ni(Se(2)PR(2))(2)] (R = (i)Pr, (t)Bu and Ph) and their use as single source precursors for the deposition of nickel phosphide or nickel selenide nanoparticles.
2009-03-28
Formation of close-packed nanoparticle chains.
2009-02
Effect of template removal methods on physical properties and catalytic performance of Co-HMS.
2009-02
Quantum dots for live cell and in vivo imaging.
2009-02
Synthesis of Monodisperse Nanocrystals via Microreaction: Open-to-Air Synthesis with Oleylamine as a Coligand.
2009-01-22
Iron nanoparticle growth in organic superstructures.
2009-01-21
Understanding of the formation of mesostructured alkylammonium-alkaline earth metal phosphates composed of ionic frameworks.
2009-01
Template free synthesis of mesoporous TiO2 with high wall thickness and nanocrystalline framework.
2009-01
Amphiphilic poly(hydroxyethylaspartamide) derivative-based micelles as drug delivery systems for ferulic acid.
2009-01
Adsorption of methylene blue and orange II onto unmodified and surfactant-modified zeolite.
2008-12-15
Catalytic desulfurization of dibenzothiophene with palladium nanoparticles.
2008-12-01
A facile route for the synthesis of poly(N-vinylcarbazole)/manganese sulphide quantum dots nanocomposites with enhanced optical properties.
2008-11
Dependence of luminescence efficiency of cdse quantum dots on chemical environments.
2008-11
Preparation and characterization of highly fluorescent, glutathione-coated near infrared quantum dots for in vivo fluorescence imaging.
2008-10
Synthesis of undoped and manganese-doped hgte nanoparticles using [Hg(TeCH2CH2NMe2)2] as a single source precursor.
2008-09
Time-dependent photoluminescence spectroscopy as a tool to measure the ligand exchange kinetics on a quantum dot surface.
2008-08
Probing hot electron flow generated on Pt nanoparticles with Au/TiO2 Schottky diodes during catalytic CO oxidation.
2008-08
The preparation of highly active antimicrobial silver nanoparticles by an organometallic approach.
2008-05-07
Fe1-yO nanoparticles: organometallic synthesis and magnetic properties.
2008-04-04
An evaluation and comparison of shear bond strength of composite resin to dentin, using newer dentin bonding agents.
2008-04
Large-scale preparation of CdS quantum dots by direct thermolysis of a single-source precursor.
2008-01-23
Quantum mazes: luminescent labyrinthine semiconductor nanocrystals having a narrow emission spectrum.
2007-11
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Mycobacterium tuberculosis were used for activity evaluation. Optical bottom black 96 well plates were used for the screening of the compounds. The Cetylamine was tested in triplicate and tested over three serial dilutions, starting at a concentration of 500 mg/mL, with repeated serial dilutions at a lower concentrations being performed on compounds showing initial inhibitory activity. Ethambutol was used as a positive control. To determine if the compounds had any inherent redox potential which might affect readouts, 200 lL solutions of compounds and PBS were added to individual control wells. Control wells of bacteria only, and PBS medium only were also prepared. 100 lL of BCG solution was added to all wells except the PBS only and compound only wells, and the plate was incubated at 37 C and 5% CO2 for 7 days. Alamar Blue dye (20 lL) was then added to all test wells on day 7, and the plate was incubated for another 24 h before fluorescence was measured (excitation at 544 nm, emission at 590 nm) using a FLUOstar OPTIMA plate reader. The results were graphed to determine the MICs. The lowest drug concentration effecting 100% growth inhibition was considered the MIC.
Substance Class Chemical
Created
by admin
on Tue Apr 01 19:07:19 GMT 2025
Edited
by admin
on Tue Apr 01 19:07:19 GMT 2025
Record UNII
NU4N3JF34G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-Hexadecanamine, acetate
Preferred Name English
Hexadecylammonium acetate
Systematic Name English
1-Hexadecanamine, acetate (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90173994
Created by admin on Tue Apr 01 19:07:19 GMT 2025 , Edited by admin on Tue Apr 01 19:07:19 GMT 2025
PRIMARY
CAS
2016-52-6
Created by admin on Tue Apr 01 19:07:19 GMT 2025 , Edited by admin on Tue Apr 01 19:07:19 GMT 2025
PRIMARY
FDA UNII
NU4N3JF34G
Created by admin on Tue Apr 01 19:07:19 GMT 2025 , Edited by admin on Tue Apr 01 19:07:19 GMT 2025
PRIMARY
PUBCHEM
16227
Created by admin on Tue Apr 01 19:07:19 GMT 2025 , Edited by admin on Tue Apr 01 19:07:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
217-954-0
Created by admin on Tue Apr 01 19:07:19 GMT 2025 , Edited by admin on Tue Apr 01 19:07:19 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE